Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

HAEMATO, MBH Corporation, USU Software - on the right path in 2020

The year 2020 will be a special year. The Corona Pandemic has turned many industries upside down. The travel industry and restaurants, for example, have enormous challenges to overcome and many companies will not make it despite government support. However, there are also busi...
Mario Hose | September 3, 2020 |

Resource Update on Canadian Gold Property Due Early Q1/20

The status and review of a few aspects of this project are provided in a Canaccord Genuity report. In a Dec. 18 research note, Canaccord Genuity analyst Eric Zaunscherb provided updates on Marathon Gold Corp.'s (MOZ:TSX; MGDPF:OTCMKTS) Valentine gold project, includ...
Streetwise Reports | December 30, 2019 |

Fiscal Year 'Reads Well' for Regenerative Medicine Company

The firm's final quarter and full-year results are reviewed in a Ladenburg Thalmann report. In an Aug. 30 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported Mesoblast Ltd.'s (MESO:NASDAQ; MSB:ASX) financial results for Q4/19 and fiscal year 2019 (FY19)...
Streetwise Reports | September 5, 2019 |

Selecting Silver Miners for October 2019

Gold and silver are our main focus, no doubt about it. But they are only a part of the precious metals market. Actually, there is another side of the market which could be overlooked by investors starting to look into the precious metals market. So, we would like to take some ...
Mike McAra | October 16, 2019 |

Facing Low Oil Prices, Energy Firm Reduces 2020 Capex, Guidance

The latest moves of Frontera Energy in response to depressed oil prices and its ability to endure the downturn are addressed in a CIBC report. In a March 23 research note, CIBC analyst Dave Popowich reported that Frontera Energy Corp. (FEC:TSX; FECCF:OTCMKT...
Streetwise Reports | March 27, 2020 |

Occidental Petroleum in Bidding War to Acquire Anadarko

The firm's move and its potential outcomes were discussed in a Raymond James report. In an April 24 research note, Raymond James analyst Pavel Molchanov reported that in fact Occidental Petroleum Corp. (OXY:NYSE) has entered into a bidding war against Che...
Streetwise Reports | April 30, 2019 |

Buffett to Invest $10 Billion in Occidental Should It Prevail in Anadarko Fight

The details and implications of this financial commitment were discussed in a Raymond James report. In an April 30 research note, Raymond James analyst Pavel Molchanov reported that Warren Buffett's Berkshire Hathaway has committed to investing $10 billion i...
Streetwise Reports | May 3, 2019 |

Chevron 'Makes a Wise Decision' in Withdrawing from Bidding War

Thoughts on the latest development and answers to some related lingering questions are provided in a Raymond James report. In a May 9 research note, Raymond James analyst Pavel Molchanov reported that Chevron Corp. (CVX:NYSE) bowed out of the acquisition b...
Streetwise Reports | May 14, 2019 |

Clinical Trial Starts for Biopharma's Antifungal in Cryptococcal Meningitis

The details of this study and a second one are outlined in a ROTH Capital Partners report. In an Oct. 16 research note, ROTH Capital Partners analyst Jerry Isaacson reported that Matinas BioPharma Holdings Inc. (MTNB:NYSE.American) launched its first clinical trial ...
Streetwise Reports | October 23, 2019 |

Analyst: Biotech to Have 'Eventful Year' with Data Readouts in Three Indications

This California company expects results from clinical trials in liver disease and psoriasis in 2019. In a March 8 research note, H.C. Wainwright & Co. analyst Ed Arce reported that DURECT Corp. (DRRX:NASDAQ) continues advancing clinical trials evaluating its lead prod...
Streetwise Reports | March 14, 2019 |
1 2 3 4 5 6 7 8 9 10 ...